Dimensions of Executive Function in Parkinson’s Disease

Background: Executive impairment is common in Parkinson’s disease (PD). However, it is unknown which dimensions of executive function are assessed by commonly used neuropsychological instruments and if clinical correlates of specific dimensions exist. Method: A convenience sample of 46 PD patients was evaluated with three executive function tests: the Tower of London-Drexel, the Trail-Making Test and the Stroop Color-Word Test. Factor analysis was used to probe for dimensions of executive control, and linear regression models were used to explore the association between the generated factors and other clinical features. Results: Factor analysis revealed two executive factors, one related to planning (eigenvalue = 4.2) and the other to inhibitory control (eigenvalue = 1.8), together accounting for 75% of the variance in scores. In linear regression models, poorer planning was associated with increasing severity of apathy (t = 2.11, p = 0.041), and diminished inhibitory control was associated with increasing severity of parkinsonism (t = 2.78, p = 0.008) and lower educational level (t = –2.23, p = 0.032). Conclusions: Planning deficits and diminished inhibitory control are two dimensions of executive impairment in PD, the former associated with decreased motivation and the latter with increased motor slowing. Similar performance on both executive and non-executive components of these instruments suggests that results of executive testing in PD may be confounded by non-executive deficits.

[1]  Roshan Cools,et al.  Using executive heterogeneity to explore the nature of working memory deficits in Parkinson’s disease , 2003, Neuropsychologia.

[2]  K. Jellinger The association of incident dementia with mortality in PD , 2003, Neurology.

[3]  R. Chervin Epworth sleepiness scale? , 2003, Sleep medicine.

[4]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[5]  R. Bakay,et al.  Cognitive impairments in advanced PD without dementia , 2002, Neurology.

[6]  J. Cummings,et al.  Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[7]  V. Tronnier,et al.  Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. , 2002, Brain : a journal of neurology.

[8]  Akinori Nakamura,et al.  Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study. , 2002, Brain : a journal of neurology.

[9]  I. Appollonio,et al.  Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[10]  A. Brück,et al.  Positron emission tomography shows that impaired frontal lobe functioning in Parkinson’s disease is related to dopaminergic hypofunction in the caudate nucleus , 2001, Neuroscience Letters.

[11]  J. Cohen,et al.  Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. , 2000, Science.

[12]  A. Dagher,et al.  Mapping the network for planning: a correlational PET activation study with the Tower of London task. , 1999, Brain : a journal of neurology.

[13]  L. Defebvre,et al.  Impairment of the supervisory attentional system in early untreated patients with Parkinson’s disease , 1999, Journal of Neurology.

[14]  M. Iyo,et al.  Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for β‐CFT binding with positron emission tomography , 1999, Annals of neurology.

[15]  A. Owen Cognitive planning in humans: Neuropsychological, neuroanatomical and neuropharmacological perspectives , 1997, Progress in Neurobiology.

[16]  R. Leiguarda,et al.  Cognitive functions in major depression and Parkinson disease. , 1997, Archives of neurology.

[17]  Bernard Pillon,et al.  Cognitive deficits in Parkinson’s disease , 1996, Journal of Neurology.

[18]  J. Cummings,et al.  Frequency of dementia in Parkinson disease. , 1996, Archives of neurology.

[19]  A. Tröster,et al.  Neuropsychological impairment in Parkinson's disease with and without depression. , 1995, Archives of neurology.

[20]  M. Folstein,et al.  Population-based norms for the Mini-Mental State Examination by age and educational level. , 1993, JAMA.

[21]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[22]  A J Lees,et al.  Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study. , 1987, Brain : a journal of neurology.

[23]  J. Yesavage,et al.  Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .

[24]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[25]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[26]  R. Reitan Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[27]  H. Katzen,et al.  Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease. , 2005, Advances in neurology.

[28]  J. Ridley Studies of Interference in Serial Verbal Reactions , 2001 .

[29]  Nir Giladi,et al.  Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease , 2000, Journal of Neural Transmission.

[30]  J. Stessman,et al.  Cognitive disturbances in Parkinsonian patients with depression , 1993 .

[31]  H. Mayberg,et al.  Reliability, validity, and clinical correlates of apathy in Parkinson's disease. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[32]  J. Stroop Studies of interference in serial verbal reactions. , 1992 .

[33]  S. Fahn Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[34]  B. Djahanguiri,et al.  The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.